Selected article for: "S1 protein and SARS CoV S1 protein"

Author: Chunyun Sun; Long Chen; Ji Yang; Chunxia Luo; Yanjing Zhang; Jing Li; Jiahui Yang; Jie Zhang; Liangzhi Xie
Title: SARS-CoV-2 and SARS-CoV Spike-RBD Structure and Receptor Binding Comparison and Potential Implications on Neutralizing Antibody and Vaccine Development
  • Document date: 2020_2_20
  • ID: nhq0oq8y_39
    Snippet: We then screened non-ACE2-blocking antibodies raised from SARS-CoV RBD for neutralizing activities. Three such monoclonal antibodies were identified. Although, binding affinities to SARS-CoV S1 protein was significantly lower with EC 50 between 55 to 224 μg/mL as compared to 16 to 42 μg/mL EC 50 for the four ACE2-blocking nAbs, significant cross-binding activities to SARS-CoV-2 S1 protein and modest cross-neutralizing activities against SARS-Co.....
    Document: We then screened non-ACE2-blocking antibodies raised from SARS-CoV RBD for neutralizing activities. Three such monoclonal antibodies were identified. Although, binding affinities to SARS-CoV S1 protein was significantly lower with EC 50 between 55 to 224 μg/mL as compared to 16 to 42 μg/mL EC 50 for the four ACE2-blocking nAbs, significant cross-binding activities to SARS-CoV-2 S1 protein and modest cross-neutralizing activities against SARS-CoV-2 PSV were detected.

    Search related documents:
    Co phrase search for related documents
    • activity neutralize and cross neutralizing activity: 1, 2
    • activity neutralize and μg ml: 1
    • activity neutralize and monoclonal antibody: 1, 2
    • activity neutralize and S1 protein: 1, 2
    • activity neutralize and SARS CoV S1 protein: 1
    • activity neutralize and SARS PSV cross neutralizing activity: 1
    • activity neutralize and SARS S1 protein: 1
    • bind affinity and cross neutralizing activity: 1, 2
    • bind affinity and μg ml: 1, 2
    • bind affinity and monoclonal antibody: 1, 2, 3, 4, 5, 6
    • bind affinity and S1 protein: 1
    • bind affinity and SARS CoV S1 protein: 1
    • bind affinity and SARS S1 protein: 1
    • cross neutralizing activity and μg ml: 1
    • cross neutralizing activity and monoclonal antibody: 1, 2, 3
    • cross neutralizing activity and S1 protein: 1, 2, 3
    • cross neutralizing activity and SARS CoV S1 protein: 1, 2
    • cross neutralizing activity and SARS PSV cross neutralizing activity: 1, 2
    • cross neutralizing activity and SARS S1 protein: 1, 2